Davos Hosts Elite Longevity Investors Lunch During WEF
The streets of Davos were abuzz with discussions on longevity during this year's World Economic Forum (WEF), thanks to the "Longevity Investors Lunch". This exclusive satellite event, co-organized by Maximon and Longevity Investors, convened on January 16th, bringing together an esteemed group of scientists, academics, entrepreneurs, and investors. Their aim? To delve into the latest advancements and research in the field of longevity and rejuvenation.
This oversubscribed event saw more than 60 investors and influential thought leaders gather to showcase the remarkable progress in longevity. Key topics like the hallmarks of longevity, brain longevity, longevity supplements, and the interplay between AI and longevity were at the forefront of discussions.
Dr. Andrew Steele, biologist and author of "Ageless", captivated the audience with his talk on the scientific, investment, and regulatory implications of longevity. His insights suggested that understanding aging could spark a transformative revolution in medicine, improving lives and reshaping the human condition.
The event featured three panel discussions, moderated by Sabinije von Gaffke of Nibiru Software and Dr. Hans Keirstead from Immunis. These panels explored brain longevity, longevity supplements, and the latest in longevity and AI, featuring renowned experts and venture builders like Dr. Evelyne Yehudit Bischof and Alex Zhavoronkov, Ph.D.
Dr. Tobias Reichmuth and Marc P. Bernegger, co-founders of Maximon and Longevity Investors, opened and concluded the event, discussing the latest industry developments and the need for company building in longevity.
The upcoming "Longevity Investors Conference", set for September 24-27, 2024, in Gstaad, Switzerland, promises to continue these vital conversations, bringing more longevity leaders to the stage.
Longevity is rapidly shaping the global economy, unlocking trillions of dollars in opportunities and potentially transforming societies. Its evolution is partly due to the discovery that genetic pathways and biochemical processes can control aging rates. With the rise of this industry, longevity stands to be a substantial investment opportunity in the coming decades. Maximon, while self-financed, has also set up a Co-Investment Fund targeting CHF 100 million, further emphasizing the sector's investment appeal.
Disclaimer: Please note that the information provided in this article is based on the referenced research articles. It is essential to conduct further research and analysis before making any investment decisions. The cryptocurrency market is highly volatile, and investors should exercise caution and consult with financial professionals before engaging in cryptocurrency trading or investment activities.
